
Please try another search
CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs. Its lead product is ChemoSeed, an implantable biodegradable drug delivery technology for the delivery of chemotherapy directly into cancer tissues. The company also offers formulation and consultancy services. The company was formerly known as Amur Minerals Corporation and changed its name to CRISM Therapeutics Corporation in May 2024. CRISM Therapeutics Corporation was founded in 2016 and is based in Road Town, the British Virgin Islands.
Name | Age | Since | Title |
---|---|---|---|
Gerry Douglas Beaney | 65 | 2024 | Independent Non-Executive Director |
Christopher McConville | - | 2024 | Chief Scientific Officer & Executive Director |
Andrew Webb | - | 2024 | CEO & Executive Director |
Garth Cruickshank | - | 2025 | Member of Scientific Advisory Board |
Vinton Cheng | - | 2025 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review